![Dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct](https://file.medchemexpress.com/product_pic/hy-21623.gif "Click to View Dichloro[1,1'-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
35 Results for "
PD II
" in MedChemExpress (MCE) Product Catalog:
Products (35)
35 Results for "PD II" in MCE Product Catalog:
11
11 Publications Verification
Target:
Domaines de recherche:
PD 123319 (ditrifluoroacetate) is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.
4
4 Cited Publications
Synonyms: AM-1155; BMS-206584; PD135432
Target:
Domaines de recherche:
Gatifloxacin (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic that can cross the blood-brain barrier, with broad-spectrum antibacterial activity. Gatifloxacin inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50=0.109 μg/ml) . Gatifloxacin can be used to treat bacterial conjunctivitis in vivo.
4
4 Cited Publications
Synonyms: AM-1155 hydrochloride; BMS-206584 hydrochloride; PD135432 hydrochloride
Target:
Domaines de recherche:
Gatifloxacin hydrochloride (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml) . Gatifloxacin hydrochloride can be used to treat bacterial conjunctivitis in vivo.
1
Target:
Domaines de recherche:
Cat. No.: HY-21623
CAS No.: 95464-05-4
Cat. No.: HY-P99573
CAS No.: 2245725-04-4
Synonyms: MGD-013
Target:
Domaines de recherche:
Cat. No.: HY-W013066
CAS No.: 205319-10-4
Cat. No.: HY-121767
CAS No.: 114785-12-5
Target:
Domaines de recherche:
PD 123177 is a nonpeptide antagonist specific for angiotensin II (AII) subtype AT2 receptor in mammalian systems .
Cat. No.: HY-P99922
CAS No.: 2173096-82-5
Cat. No.: HY-W033277
CAS No.: 21797-13-7
Synonyms: NSC 307191; Palladium(II) tetrafluoroborate tetraacetonitrile complex
Domaines de recherche:
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (NSC 307191) acts as a potent Lewis acid and facilitates the formation of the 2:1 complex [Pd(1,2-bis(2′-pyridylethynyl)benzene)2](BF4)2 through the Sonogashira cross-coupling reaction.
Cat. No.: HY-10259
CAS No.: 130663-39-7
Synonyms: (S)-(+)-PD 123319
Target:
Domaines de recherche:
PD 123319 (ditrifluoroacetate) is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.
Cat. No.: HY-P4569
CAS No.: 23827-93-2
Target:
Domaines de recherche:
Cat. No.: HY-P2470
CAS No.: 2135542-85-5
Target:
Domaines de recherche:
Cat. No.: HY-W127815
CAS No.: 40680-45-3
Cat. No.: HY-105453
CAS No.: 114785-18-1
Synonyms: WL 19
Target:
Domaines de recherche:
PD 121981 is a angiotensin II receptor antagonist. PD 121981 can be used for the research of cardiovascular disease .
Cat. No.: HY-10581C
CAS No.: 180200-66-2
Synonyms: AM-1155 sesquihydrate; BMS-206584 sesquihydrate; PD135432 sesquihydrate
Target:
Domaines de recherche:
Gatifloxacin sesquihydrate (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin sesquihydrate inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml) . Gatifloxacin sesquihydrate can be used to treat bacterial conjunctivitis in vivo.
Cat. No.: HY-136417
CAS No.: 119654-64-7
Synonyms: PD(II) meso-tetraphenyltetrabenzoporphyrin
Cat. No.: HY-W112936
CAS No.: 110314-07-3
Cat. No.: HY-120857
CAS No.: 171179-37-6
Synonyms: PD 158294
BPIQ-II is a linear imidazoloquinazoline that potently inhibits the tyrosine kinase activity of the epidermal growth factor receptor (EGFR; IC50=8 pM). It is selective for EGFR over an assortment of other tyrosine and serine/threonine kinases. Cellular studies indicate that BPIQ-II can enter cells and very selectively shut down EGF-stimulated signal transmission by binding competitively at the ATP site of EGFR.
Cat. No.: HY-144746
CAS No.: 2966090-78-6
Target:
Domaines de recherche:
PD-1/PD-L1-IN-26 (Compound II-14) is a potent inhibitor of PD-1/PD-L1 with an IC50 of 0.0380 μM. PD-1/PD-L1-IN-26 activates the immune microenvironment by promoting the infiltration of CD4+ T cells into tumor tissues. PD-1/PD-L1-IN-26 has the potential for the research of cancer diseases .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
